Irvine Pathology Med Group Inc is categorized under Pathological Laboratories in Irvine, CA and active since 1992.
Irvine Pathology Med Group Inc was established in 1992, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Pathological Laboratories business, which does work in the B2C market, and is classified as a Pathological Laboratories, under code number 6215112 by the NAICS.
If you are seeking more information, feel free to contact Alan Rushovich at the company’s single location by writing to 15375 Barranca Parkway # H105, Irvine, California CA 92618 or by phoning (949) 387-8111. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Irvine Pathology Med Group Inc |
| Contact Person: | Alan Rushovich |
| Address: | 15375 Barranca Parkway # H105, Irvine, California 92618 |
| Phone Number: | (949) 387-8111 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1992 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Pathological Laboratories |
| SIC Code: | 8071 |
| NAICS Code: | 6215112 |
| Share This Business: |
Irvine Pathology Med Group Inc was started in 1992 to provide professional Pathological Laboratories under the SIC code 8071 and NAICS code 6215112. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Alan Rushovich for inquiries that concern Irvine Pathology Med Group Inc by calling the company number (949) 387-8111, as your correspondence is most welcome. Additionally, the physical location of the single location of Irvine Pathology Med Group Inc can be found at the coordinates 33.661731,-117.74381 as well as the street address 15375 Barranca Parkway # H105 in Irvine, California 92618.
For its online presence, you may visit Irvine Pathology Med Group Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.